Chemistry

Comparative effectiveness of medicine used to constrict the patent ductus arteriosus: a secondary evaluation of the PDA-TOLERATE trial (NCT01958320)


1.

Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a delivery weight of 1000 grams or much less. Pediatrics. 2006;117:1113–21.

2.

Nemerofsky SL, Parravicini E, Bateman D, Kleinman C, Polin RA, Lorenz JM. The ductus arteriosus not often requires remedy in infants > 1000 grams. Am J Perinatol. 2008;25:661–6.

three.

Sung SI, Chang YS, Chun JY, Yoon SA, Yoo HS, Ahn SY, et al. Obligatory closure versus nonintervention for patent ductus arteriosus in very preterm infants. J Pediatr. 2016;177:66–71.

four.

Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a shocking new strategy to patent ductus arteriosus remedy. Pediatrics. 2011;128:e1618–21.

5.

Allegaert KS, Anderson B, Simons S, Van Overmeire B. Paracetamol to induce ductus arteriosus closure: is it legitimate? Arch Dis Youngster. 2013;98:462–6.

6.

El-Khuffash A, Jain A, Corcoran D, Shah PS, Hooper CW, Brown N, et al. Efficacy of paracetamol on patent ductus arteriosus closure could also be dose dependent: proof from human and murine research. Pediatr Res. 2014;76:238–44.

7.

Al-Lawama M, Alammori I, Abdelghani T, Badran E. Oral paracetamol versus oral ibuprofen for remedy of patent ductus arteriosus. J Int Med Res. 2018;46:811–eight.

eight.

Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparability of oral paracetamol versus ibuprofen in untimely infants with patent ductus arteriosus: a randomized managed trial. PLoS ONE. 2013;eight:e77888.

9.

Sprint SK, Kabra NS, Avasthi BS, Sharma SR, Padhi P, Ahmed J. Enteral paracetamol or Intravenous Indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized managed trial. Indian Pediatr. 2015;52:573–eight.

10.

El-Mashad AE, El-Mahdy H, El Amrousy D, Elgendy M. Comparative research of the efficacy and security of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr. 2017;176:233–40.

11.

Harkin P, Harma A, Aikio O, Valkama M, Leskinen M, Saarela T, et al. Paracetamol accelerates closure of the ductus arteriosus after untimely delivery: a randomized trial. J Pediatr. 2016;177:72–7.

12.

Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, et al. Oral paracetamol versus oral ibuprofen within the administration of patent ductus arteriosus in preterm infants: a randomized managed trial. J Pediatr. 2014;164:510–four.

13.

Yang B, Gao X, Ren Y, Wang Y, Zhang Q. Oral paracetamol vs. oral ibuprofen within the remedy of symptomatic patent ductus arteriosus in untimely infants: A randomized managed trial. Exp Ther Med. 2016;12:2531–6.

14.

Bagheri MM, Niknafs P, Sabsevari F, Torabi MH, Bahman Bijari B, Noroozi E, et al. Comparability of Oral Acetaminophen Versus Ibuprofen in Untimely Infants With Patent Ductus Arteriosus. Iran J Pediatr. 2016;26:e3975.

15.

El-Farrash RA, El Shimy MS, El-Sakka AS, Ahmed MG, Abdel-Moez DG. Efficacy and security of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized managed trial. J Matern Fetal Neonatal Med. 2018:1–eight. https://doi.org/10.1080/14767058.2018.1470235. [Epub ahead of print]

16.

Asbagh PA, Zarkesh MR, Nili F, Sadat Nayeri FS, Naeem AT. Prophylactic remedy with oral paracetamol for patent ductus arteriosus in preterm infants: a randomized medical trial. Tehran Univ Med J. 2015;73:86–92.

17.

Terrin G, Conte F, Oncel MY, Scipione A, McNamara PJ, Simons S, et al. Paracetamol for the remedy of patent ductus arteriosus in preterm neonates: a scientific evaluation and meta-analysis. Arch Dis Youngster Fetal Neonatal Ed. 2016;101:F127–36.

18.

Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low delivery weight infants. Cochrane Database Syst Rev. 2018;four:CD010061.

19.

Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, et al. Affiliation of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically important patent ductus arteriosus in preterm infants: a scientific evaluation and Meta-analysis. JAMA. 2018;319:1221–38.

20.

Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Hakansson S, et al. PDA-TOLERATE trial: an exploratory randomized managed trial of remedy of moderate-to-large patent ductus arteriosus at one week of age. J Pediatr. 2018;205:41–7.

21.

Schena F, Francescato G, Cappelleri A, Picciolli I, Mayer A, Mosca F, et al. Affiliation between hemodynamically important patent ductus arteriosus and bronchopulmonary dysplasia. J Pediatr. 2015;166:1488–92.

22.

Sellmer A, Bjerre JV, Schmidt MR, McNamara PJ, Hjortdal VE, Host B, et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day three. Arch Dis Youngster Fetal Neonatal Ed. 2013;98:F505–10.

23.

Jhaveri N, Moon-Grady A, Clyman RI. Early surgical ligation versus a conservative strategy for administration of patent ductus arteriosus that fails to shut after indomethacin remedy. J Pediatr. 2010;157:381–7.

24.

El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L. Severity of the ductal shunt: a comparability of various markers. Arch Dis Youngster Fetal Neonatal Ed. 2005;90:F419–22.

25.

Hochwald O, Mainzer G, Borenstein-Levin L, Jubran H, Dinur G, Zucker M, et al. Including paracetamol to ibuprofen for the remedy of patent ductus arteriosus in preterm infants: a double-blind, randomized, placebo-controlled pilot research. Am J Perinatol. 2018. https://doi.org/10.1055/s-0038-1653946.

26.

Furzan JA, Reisch J, Tyson JE, Laird P, Rosenfeld CR. Incidence and danger components for symptomatic patent ductus arteriosus amongst inborn very-low-birth-weight infants. Early Hum Dev. 1985;12:39–48.

27.

Clyman RI, Ballard PL, Sniderman S, Ballard RA, Roth R, Heymann MA, et al. Prenatal administration of betamethasone for prevention of affected person ductus arteriosus. J Pediatr. 1981;98:123–6.

28.

Chorne N, Jegatheesan P, Lin E, Shi R, Clyman RI. Threat components for persistent ductus arteriosus patency throughout indomethacin remedy. J Pediatr. 2007;151:629–34.

29.

Durrmeyer X, Hovhannisyan S, Medard Y, Jacqz-Aigrain E, Decobert F, Barre J, et al. Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms related to ibuprofen response in very preterm infants? PLoS ONE. 2010;5:e12329.

30.

Cotton RB, Haywood JL, FitzGerald GA. Symptomatic patent ductus arteriosus following prophylactic indomethacin. A medical and biochemical appraisal. Biol Neonate. 1991;60:273–82.

31.

Waleh N, Barrette AM, Dagle JM, Momany A, Jin C, Hills NK, et al. Results of advancing gestation and non-caucasian race on ductus arteriosus gene expression. J Pediatr. 2015;167:1033–41.

32.

Shelton EL, Waleh N, Plosa EJ, Benjamin JT, Milne GL, Hooper CW, et al. Results of antenatal betamethasone on preterm human and mouse ductus arteriosus: comparability with baboon information. Pediatr Res. 2018. https://doi.org/10.1038/s41390-Zero18-0006-z.

33.

Momma Okay, Takao A. Transplacental cardiovascular results of 4 in style analgesics in rats. Am J Obstet Gynecol. 1990;162:1304–10.

34.

Momma Okay, Hagiwara H, Konishi T. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory medication: research of extra 34 medication. Prostaglandins. 1984;28:527–36.

35.

Sancak S, Gokmen Yildirim T, Topcuoglu S, Yavuz T, Karatekin G, Ovali F. Oral versus intravenous paracetamol: which is best in closure of patent ductus arteriosus in very low delivery weight infants? J Matern Fetal Neonatal Med. 2016;29:135–9.

36.

Bin-Nun A, Fink D, Mimouni FB, Algur N, Hammerman C. Paracetamol serum concentrations in neonates handled enterally for ductal closure: a pilot research. J Pediatr. 2018;198:304–7.

37.

Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for stopping mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010:CD000174. https://doi.org/10.1002/14651858.CD000174.pub2.

38.

Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low delivery weight infants. Cochrane Database Syst Rev. 2011:CD004213. https://doi.org/10.1002/14651858.CD004213.pub3.

39.

van den Anker JN, Allegaert Okay. Acetaminophen within the neonatal intensive care unit: shotgun strategy or silver bullet. J Pediatr. 2018;198:10–1.


Supply hyperlink
asubhan

wordpress autoblog

amazon autoblog

affiliate autoblog

wordpress web site

web site growth

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close